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Abstract
RhoGDIβ, a Rho GDP dissociation inhibitor, induced hypertrophic growth and cell migration in a
cultured cardiomyoblast cell line, H9c2. We demonstrated that RhoGDIβ plays a previously
undefined role in regulating Rac1 expression through transcription to induce hypertrophic growth
and cell migration and that these functions are blocked by the expression of a dominant-negative
form of Rac1. We also demonstrated that knockdown of RhoGDIβ expression by RNA
interference blocked RhoGDIβ-induced Rac1 expression and cell migration. We demonstrated
that the co-expression of ZAK and RhoGDIβ in cells resulted in an inhibition in the activity of ZAK
to induce ANF expression. Knockdown of ZAK expression in ZAK-RhoGDIβ-expressing cells by
ZAK-specific RNA interference restored the activities of RhoGDIβ.
Background
The mitogen-activated protein kinase (MAPK) signaling
pathway consists of the sequentially acting upstream
kinases MAPK kinase kinase (MAP3K) and MAPK kinase
(MAP2K), and the downstream MAPKs, p38MAPK, extra-
cellular signal-regulated kinase (ERK1/2), and c-jun N-ter-
minal kinase (JNK). The mixed lineage kinases are a
family of serine/threonine kinases, all of which are classi-
fied as MAP3Ks. The seven mixed lineage kinases cloned
over the past several years can be classified into three sub-
families based on domain organization and sequence
similarity: the MLKs (MLK1–4), the dual leucine zipper-
bearing kinases (DLK and LZK), and the zipper sterile-α-
motif (SAM) kinases (ZAKα and ZAKβ) [1,2]. ZAK can
activate the JNK pathway and the nuclear factor κB
(NFκB) pathway [3], and it induces JNK activation
through a dual phosphorylation kinase, JNKK2/MKK7
[4]. Overexpression of wild-type ZAK induced apoptosis
in a hepatoma cell line [3], and a recent report indicated
that ZAK expression in a rat cardiac cell line, H9c2,
induced hypertrophic growth and re-expression of atrial
natriuretic factor (ANF) [5]. ZAK also mediates TGF-β-
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induced cardiac hypertrophic growth via a novel TGF-β
signaling pathway [6]. In our previous study [5], we
showed that the leucine zipper of ZAK mediates
homodimerization and promotes autophosphorylation
and JNK activation.
We identified RhoGDIβ(Rho GDP dissociation inhibitor
beta) as a ZAK effector. RhoGDIβ, also known as Ly-GDI
or D4-GDI, belongs to a family of Rho GDP dissociation
inhibitors, and it is thought to regulate the activity and
localization of Rho family proteins [7-10]. The RhoGT-
Pase family includes Rho, Rac, and Cdc42, which differen-
tially regulate the actin cytoskeleton [11-13] and function
as molecular switches in cellular signal transduction by
alternating between an inactive GDP-bound form that is
maintained in cytosolic complexes with GDIs and a GTP-
bound form that usually associates with the plasma mem-
brane and interacts with downstream target proteins
therein [14,15]. RhoGTPases regulate the reorganization
of the actin cytoskeleton and the integrity of the integrin-
associated adhesion complexes [16]. Rho facilitates stress
fiber and focal adhesion assembly, Rac regulates the for-
mation of lamellipodia and membrane ruffles at the lead-
ing edge of migrating cells, and Cdc42 triggers filopodia at
the cell periphery [17]. RhoGDIs regulate RhoGTPase
activity by inhibiting GDP dissociation to keep RhoGT-
Pases in an inactive state.
A recent study indicated that stimulation of T lym-
phocytes and myelomonocytic cells with phorbol esters
leads to RhoGDIβ phosphorylation on serine/threonine
residues [18], raising the question of whether RhoGDIβ is
involved in a signal transduction pathway in these cells.
Thus, RhoGDIβ may play numerous roles in the regula-
tion of biological activities; however, many details of the
regulatory roles of RhoGDIβ remain to be elucidated.
Materials and methods
Northern blot analysis
Trizol reagents (Life Technologies) were used to isolate
total RNA from H9c2 cells transiently transfected with the
recombinant RhoGDIβ plasmids or from cells stably
expressing RhoGDIβ. Total RNA (20 μg) was separated on
a formaldehyde agarose gel, transferred to a nylon filter,
and then hybridized with a probe corresponding to the
full-length Rac1 cDNA labeled using the NEBlot random
labeling kit (New England BioLabs) in the presence of [α-
32P]dCTP. The blot was washed with SSC/SDS solutions
(Sodium Chloride, Sodium Citrate/SDS) before autoradi-
ography. Ethidium bromide staining was used to check
the integrity of all samples.
Wound healing assay
H9c2 cells seeded on 10-cm plates were cultured to con-
fluency. They were then scratched with a 200 μl pipette tip
and further incubated in DMEM supplemented with 10%
FBS. Images were taken at 24, 48, and 72 h with a Zeiss
Axiovert 200 microscope. The Image-Pro image analysis
system was used to measure the lesion area. The data were
expressed as the percentage of recovery (WC%) using the
equation: WC% = [1 - (wounded area at Tt/wounded area
at T0)] × 100%, where Tt is the number of hours post-
injury and T0 is the time of injury.
Membrane and cytosol fractionation
H9c2 cells were cultured with 1 μg/ml doxycycline for 48
h and then treated with lysis buffer (20 mM Tris-HCl, pH
7.5, 100 mM NaCl, 5 mM EDTA, 2 mM PMSF, 1× protease
inhibitor) at 4°C for 30 min. The samples were centri-
fuged at 500 × g at 4°C for 10 min, and the pellets were
dissolved in lysis buffer plus 0.1% (w/v) Triton X-100 for
the membrane fractions. The supernatants were re-centri-
fuged at 15,000 rpm at 4°C for 20 min, and the superna-
tants were saved as cytosolic fractions.
Results
Expression of RhoGDIβ induces hypertrophic growth via 
modulation of Rac1 expression in cardiac cells
The RhoGTPases act as molecular switches by cycling
between the inactive GDP-bound form located in the
cytoplasm and an active membrane-associated GTP-
bound form. The activities of Rho family proteins are reg-
ulated by various proteins, such as guanine nucleotide
exchange factors (GEFs), GTPase activating proteins
(GAPs), and GDIs. The functions and binding of RhoG-
DIα to RhoA, Rac1, and Cdc42 are well studied; however,
the functions and targets for RhoGDIβ remain unclear, as
it binds poorly to RhoA, Rac1, and Cdc42. We therefore
sought to determine whether RhoGDIβ stimulates the
expression or activities of these GTPases in cardiac cells by
western blotting. The total RhoA and Cdc42 levels
remained the same; however, cells overexpressing
RhoGDIβ had increased levels of Rac1 (Figure 1A). More-
over, the expression of RhoGDIα in H9c2 cells was not
affected by the overespression RhoGDIβ (Figure 1A). The
expression levels of Rac1 may be causally linked to
RhoGDIβ expression or merely an epiphenomenon of the
selection of a stable clone. If the former is the case, then
Rac1 might be a functionally important downstream tar-
get of RhoGDIβ. Northern blot analysis of total RNA indi-
cated that cardiac cells either stably or transiently
overexpressing RhoGDIβ had increased Rac1 mRNA levels
(Figure 1B). We therefore concluded that RhoGDIβ plays
a role in the transcriptional regulation of Rac1 and that
the increased level of Rac1 mRNA was not a secondary
effect of the selection of a stable RhoGDIβ-expressing
clone. Rac1 association with membranes reflects its bio-
logical activity [19]. To further address the question of
whether induction of Rac1 may also influence Rac1 activ-
ity, a detergent-insoluble membrane fraction was pre-Journal of Biomedical Science 2009, 16:56 http://www.jbiomedsci.com/content/16/1/56
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pared from RhoGDIβ-overexpressing cells, and the levels
of membrane-associated Rac1 were determined by west-
ern blotting. Both the levels of membrane-associated Rac1
and cytosolic Rac1 increased in RhoGDIβ-overexpressing
cells (Figure 1C). Furthermore, the membrane-associated
and cytosolic forms of Cdc42 remained unchanged in
RhoGDIβ-expressing cells when compared to parental
cells. We further detect the amount of GTP-bound Rac1 in
H9c2 RhoGDIβ-overexpressing cells. We found that
RhoGDIβ increased GTP loading in Rac1 (Figure 1D).
Therefore, overexpression of RhoGDIβ in H9c2 cells
increases the level of membrane-associated Rac1 and GTP
loading in RAC1 by upregulating Rac1 transcripts. How-
ever, the increase in membrane-associated Rac1 in
RhoGDIβ-expressing cells may be a secondary effect of
increased expression of Rac1, as we were not able to detect
any physical interaction between RhoGDIβ and Rac1 by
co-immunoprecipitation.
Effects of RhoGDIβ on Rac1 expression and subcellular localization of RhoGTPases Figure 1
Effects of RhoGDIβ on Rac1 expression and subcellular localization of RhoGTPases. (A) RhoGDIβ, RhoGDIβ, Rho, 
CDC42, and Rac1 were detected by western blotting of cell lysates from H9c2 cells stably expressing RhoGDIβ. (B) Total 
RNA was isolated from H9c2 cells stably or transiently expressing RhoGDIβ. Rac1 transcripts were analyzed by northern blot-
ting. The lower EtBr panels of (B) represent the 28S and 18S loading controls. (C) Membrane (Mem.) and cytosolic (Cyto.) 
fractions from H9c2 control (C) and RhoGDIβ-expressing cells were analyzed by immunoblotting for Rac1, Cdc42, and 
RhoGDIβ. (D) GTP loading in Rac1 was determined utilized PAK PBD binding assay in H9c2 cells stably expressing RhoGDIβ.Journal of Biomedical Science 2009, 16:56 http://www.jbiomedsci.com/content/16/1/56
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We next examined whether Rac1 mediates RhoGDIβ-
induced hypertrophic growth. We found that H9c2 cells
stably expressing a dominant-negative form of Rac1
(Rac1N17) and RhoGDIβ significantly reduced the two-
fold increase in cell size (Figure 2A) and actin organiza-
tion induced by RhoGDIβ. Moreover, overexpression of
wild-type or a constitutively active (V12) Rac1 in H9c2
cells was sufficient to induce hypertrophic growth (Figure
2A) and actin organization. These findings indicate that
the RhoGDIβ-induced hypertrophic growth in H9c2 cells
is mediated through increased expression of Rac1, and
probably through increased levels of membrane-associ-
ated Rac1.
H9c2 cell migration promoted by RhoGDIβ is Rac1 
dependent
Rac1 is able to regulate cell migration [20]. To test
whether the effect of RhoGDIβ on cell migration is Rac1
dependent, confluent monolayers of cells stably express-
ing RhoGDIβ, RhoGDIβ and Rac1, or RhoGDIβ and
Rac1N17 were scrape-wounded with a sterile plastic
pipette, and the migration of cells into the wound was
monitored. The RhoGDIβ-expressing cells closed the
RhoGDIβ-induced hypertrophic growth and cell migration is Rac1-dependent, but suppression of cell cycle progression is not Figure 2
RhoGDIβ-induced hypertrophic growth and cell migration is Rac1-dependent, but suppression of cell cycle 
progression is not. (A) Control H9c2 and H9c2 RhoGDIβ-expressing cells stably transfected with Rac1, Rac1N17, or 
Rac1V12 were grown in 10% fetal bovine serum with doxycycline for three days, and the cell size was determined. (B) Wound-
healing assay. The cell lines were seeded on plates, as previously described. After reaching confluency, the cell layer was 
wounded with a 200 μl pipette tip and incubated for 48 h with medium and doxycycline. (C) SiRNA knockdown of RhoGDIβ 
inhibited RhoGDIβ-induced Rac1 expression levels in H9c2 cells. U6-Ci is the scramble control siRNA, and both U6-353i and 
U6-568i are two specific RhoGDIβ siRNAs.Journal of Biomedical Science 2009, 16:56 http://www.jbiomedsci.com/content/16/1/56
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wound area faster than control cells (Figure 2B).
RhoGDIβ-expressing cells that also expressed a dominant-
negative form of Rac1N17 migrated slower than
RhoGDIβ-expressing or RhoGDIβ- and Rac1-expressing
cells (Figure 2B), suggesting that Rac1 plays a key role in
mediating cell migration in RhoGDIβ-expressing cells.
RhoGDIβ-induced cell migration does not correlate with 
cell proliferation
To determine whether Rac1 might play a role in the
RhoGDIβ-mediated cell cycle arrest, we examined the
growth rate of cells expressing both RhoGDIβ and
Rac1N17 and found that it was substantially slower than
the growth rate of RhoGDIβ-expressing cells or control
cells (Additional file 1). Therefore, the RhoGDIβ-regu-
lated cell arrest was not mediated through increased levels
of membrane-bound active Rac1.
Since the cyclin-dependent kinase inhibitors p21Waf1/Cip1
and p27Kip1 were expressed in RhoGDIβ-expressing cells at
higher levels than they were in control cells, we examined
p21Waf1/Cip1 and p27Kip1 levels in RhoGDIβ- and Rac1N17-
expressing cells to study the effects of this dominant-neg-
ative form of Rac1 on the expression of p21 and p27.
RacN17 was unable to block the expression of p21Waf1/Cip1
and p27Kip1 induced by RhoGDIβ in H9c2 cardiac cells
(Additional file 2), suggesting that the RhoGDIβ-induced
cell cycle arrest was not mediated through Rac1.
Knockdown of overexpressed RhoGDIβ by siRNA reduces 
H9c2 cell migration
To this point, our results indicated that RhoGDIβ stimu-
lates cell migration through the induction of Rac1 expres-
sion due to a proportional increase in the activity of Rac1
in H9c2 cells. To confirm the role of RhoGDIβ in cell
migration, two RhoGDIβ knockdown cell lines were used
to assess whether RhoGDIβ directly stimulates Rac1
expression to induce cell migration. The specific knock-
down of RhoGDIβ using siRNA in H9c2 cells was con-
firmed by immunoblotting (Fig. 2C). We found that
targeted disruption of RhoGDIβ by siRNA effectively
blocked expression of Rac1 (Fig. 2C); therefore, RhoGDIβ
depletion is associated with Rac1 downregulation. We
used migration assays to confirm the role of RhoGDIβ in
cell migration. Cells were seeded in an upper chamber of
a Transwell on a porous filter, and the migration through
the filter pores of H9c2 cells expressing RhoGDIβ and
cells expressing both RhoGDIβ and RhoGDIβ- specific
siRNA was compared. RhoGDIβ-expressing cells showed
increased migration compared to parental cells, whereas
migration was inhibited in the siRNA RhoGDIβ knock-
down cells relative to the RhoGDIβ-expressing cells (Addi-
tional file 3). These results suggest that RhoGDIβ may
play a critical role in the regulation of Rac1 expression and
H9c2 cell migration.
RhoGDIβ-induced wound healing is negatively regulated 
by ZAK
Our experiments demonstrated that RhoGDIβ increased
the rate of wound closure. However, our data also sug-
gested that the physical association of ZAK with RhoGDIβ
and phosphorylation of RhoGDIβ by ZAK could abolish
RhoGDIβ function. To identify the regulatory role of ZAK
on cell migration responses in RhoGDIβ-expressing cells,
a wound-healing assay was performed using cells express-
ing RhoGDIβ, ZAK and RhoGDIβ, or ZAKdn and
RhoGDIβ. After wounding, control, ZAK-expressing, and
ZAKdn-expressing cells closed the gap at a similar rate
(Figure 3A). As demonstrated above, RhoGDIβ-expressing
cells were highly migratory, but ZAK- and RhoGDIβ-
expressing cells were substantially slower to close the
wound than ZAKdn- and RhoGDIβ-expressing cells. At 36
h post-wounding, control, ZAK-expressing, ZAKdn-
expressing, and ZAK- and RhoGDIβ-expressing cells
closed the gap by about 20%, 24%, 25%, and 22%,
respectively (Figure 3B). RhoGDIβ-expressing cells and
ZAKdn- and RhoGDIβ-expressing cells closed 50% and
39% of the gap. These data suggested a negative regulatory
role for ZAK in RhoGDIβ cell migratory function.
To elucidate the role of RhoGDIβ in controlling the local-
ization of Rac1, we performed confocal microscopy. The
majority of Rac1 was present in the perinuclear region
with some present at the plasma membrane of the con-
trol, ZAK-expressing, and ZAKdn-expressing cells (Addi-
tional file 4). More Rac1 was present at both the plasma
membrane and the perinuclear region in RhoGDIβ-
expressing cells. However, co-expression of ZAK, but not
ZAKdn, with RhoGDIβ in H9c2 cardiac cells decreased the
amount of Rac1 at the plasma membrane (Additional file
4). These data also suggested that ZAK might decrease the
total amount of cellular Rac1, probably due to ZAK bind-
ing and phosphorylation of RhoGDIβ. To determine
whether ZAK negatively regulates RhoGDIβ through
expression of Rac1, especially membrane-associated Rac1,
we performed western blotting. Consistent with the above
experiment, membrane-associated Rac1 increased in
RhoGDIβ-expressing cells, whereas, in ZAK- and
RhoGDIβ-expressing cells, the levels of membrane-associ-
ated Rac1 decreased. However, co-expression of ZAKdn
and RhoGDIβ had no such effect (Figure 4A). In this
regard, it was of interest whether RhoGDIβ increases the
amount of Rac1 at the plasma membrane as a conse-
quence of increasing the total cellular levels of Rac1 or
whether RhoGDIβ facilitates the translocation of Rac1 to
the plasma membrane. We attempted to co-immunopre-
cipitate RhoGDIβ and Rac1to investigate this possibility;
however, the antibody used was insufficient for this pur-
pose (data not shown). This suggests that it is unlikely
that RhoGDIβ facilitates translocation of Rac1 to the
plasma membrane.Journal of Biomedical Science 2009, 16:56 http://www.jbiomedsci.com/content/16/1/56
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ZAK reverses the effects of RhoGDIβ on the induction of cell migration in H9c2 cells Figure 3
ZAK reverses the effects of RhoGDIβ on the induction of cell migration in H9c2 cells. (A) Wound healing assay. 
H9c2 cells and H9c2 cells ectopically expressing ZAK, dominant-negative ZAK (ZAKdn), RhoGDIβ, ZAK and RhoGDIβ, or 
ZAKdn and RhoGDIβ were seeded onto plates. After reaching confluency, the cell layer was wounded with a 200 μl pipette tip 
and incubated for 72 h with medium and doxycycline. (B) The cell migration capacity at 36 h was estimated by measuring the 
percentage wound closure (WC%). Values are means (SEM from three independent experiments).Journal of Biomedical Science 2009, 16:56 http://www.jbiomedsci.com/content/16/1/56
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To test the importance of ZAK in regulating RhoGDIβ-
mediated membrane-associated Rac1 and hypertrophic
growth, we reduced the levels of ZAK using siRNA. We
were able to reduce the levels of ZAK by expressing two
different human ZAK siRNAs: ZAKGRi1 (ZAK-RhoGDIβ
U6-460i) and ZAKGRi2 (ZAK-RhoGDIβ U6-1712i) (data
not shown). The reduced levels of ZAK in these two indi-
vidual clones were able to restore the levels of membrane-
associated Rac1 to levels similar to those of RhoGDIβ-
expressing cells, whereas the introduction of a scrambled
ZAK siRNA (GRCi) into ZAK- and RhoGDIβ-expressing
cells had no effect (Figure 4B). These results confirmed the
importance of ZAK as a negative regulator of the effect of
RhoGDIβ on the expression of Rac1 and membrane-asso-
ciated Rac1. We found that ZAK was able to regulate ANF
expression. We then studied the effects of RhoGDIβ on
the regulation of ANF expression by ZAK by examining
the levels of ANF mRNA in ZAK- and RhoGDIβ-expressing
cells when compared with ZAK-expressing cells. The levels
of ANF mRNA induced by ZAK were decreased in cells
expressing both ZAK and RhoGDIβ (Fig. 4C). We also
found that ZAK-RhoGDIβ cells has less total amount of
Rac1 than RhoGDIβ cells. (Figure 4D). This result sug-
gested that RhoGDIβ negatively regulates the functions of
ZAK. Moreover, the data presented here (and consistent
with our previous studies) indicate that both ZAK and
RhoGDIβ may be hypertrophic growth inducers; however,
ZAK physically interacts with RhoGDIβ and phosphor-
ZAK specifically downregulates the activities of RhoGDIβ as a consequence of decreasing the amount of membrane-associated  Rac1 Figure 4
ZAK specifically downregulates the activities of RhoGDIβ as a consequence of decreasing the amount of mem-
brane-associated Rac1. (A) ZAK decreases the levels of membrane-associated Rac1 induced by RhoGDIβ. Control H9c2 
and transfected H9c2 cells were collected and fractionated into membrane (Mem.) and cytosolic (Cyto.) fractions by centrifu-
gation. (B) SiRNA knockdown of ZAK restores the effects of RhoGDIβ in ZAK- and RhoGDIβ-expressing cells (GRi1 and 
GRi2) upon Rac1 membrane association. (C) RhoGDIβ inhibits ZAK functions upon the induction of ANF mRNA expression. 
(D) The effect of ZAK-RhoGDIβ and RhoGDIβ on total amount of Rac1expression.Journal of Biomedical Science 2009, 16:56 http://www.jbiomedsci.com/content/16/1/56
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ylates RhoGDIβ, thus inhibiting the ability of RhoGDIβ to
induce Rac1 expression. The levels of Rac1 induced by
RhoGDIβ are associated with the closure rate of wound
healing (Figure 2B) and hypertrophic growth (Figure 2A),
but they are not associated with cell cycle inhibition
(Additional file 1). Thus, RhoGDIβ appears to play a role
in signaling pathways regulating Rac1 expression that gov-
ern wound healing and hypertrophic growth in cardiac
cells.
Discussion
Upon introduction of RhoGDIβ into rat cardiac H9c2
cells, the cells exhibited hypertrophic growth, had a
slower cell cycle, and migrated to a greater extent. We pre-
viously demonstrated that RhoGDIβ is phosphorylated by
ZAK in vitro. It is striking that the co-expression of ZAK
and RhoGDIβ in H9c2 cardiac cells results in the inhibi-
tion of the biological functions of RhoGDIβ, indicating
that not only does RhoGDIβ possibly physically interact
with ZAK, but it may also be negatively regulated by ZAK,
and this regulation might occur via phosphorylation.
These phenomena regulated by ZAK were correlated with
Rac 1 expression and especially with the levels of mem-
brane-associated Rac1 in H9c2 cells.
In H9c2 cells transiently and stably expressing RhoGDIβ,
the levels of Rac1 transcripts increased compared with
control cells. In this study, we described these surprising
findings and, to our knowledge, the first demonstration
that expression of RhoGDIβ induces Rac1 transcripts and
increases the levels of membrane-associated Rac1. The
results from western blotting and confocal microscopy
experiments indicate that RhoGDIβ regulates Rac1 expres-
sion, which leads to increased levels of membrane-associ-
ated Rac1. We propose either that the increased levels of
membrane-associated Rac1 in RhoGDIβ cells are merely a
consequence of RhoGDIβ-induced expression of Rac1 or
that RhoGDIβ regulates membrane translocation of Rac1.
We were unable to detect an association between
RhoGDIβ and Rac1 using co-immunoprecipitation; there-
fore, it is unlikely that RhoGDIβ andRac1 directly interact.
However, we still have not ruled out the possibility that
RhoGDIβ regulates Rac1 translocation. However, the sig-
naling pathway between RhoGDIβ and Rac1 has not yet
been elucidated, and there is currently no evidence that
RhoGDIβ can directly bind to any gene promoter.
RhoGDIβ can be translocated into the nucleus upon cer-
tain stimuli [21], leaving the possibility that RhoGDIβ can
regulate gene expression directly. It is also possible that
RhoGDIβ regulates Rac1 expression via signaling pathway
effector proteins. Studies have also demonstrated that
RhoGDIβ is cleaved at its N-terminus during apoptosis in
a caspase-dependent manner and that the cleaved
RhoGDIβ is retained in the nuclear compartment [22].
This suggests that RhoGDIβ could function in the nucleus.
We previously found that RhoGDIβ was able to associate
with a mixed lineage kinase, ZAK, resulting in the phos-
phorylation of RhoGDIβ. To further study the role of ZAK
in regulating the activities of RhoGDIβ, we used a bi-direc-
tional tet-on inducible system to express both ZAK and
RhoGDIβ in H9c2 cardiac cells. Our results demonstrate
that the levels of membrane-associated Rac1 and the
hypertrophic growth phenotype were inhibited by co-
expression of ZAK and RhoGDIβ; however, we did not
observe the inhibitory effect with a dominant-negative
form of ZAK. Clearly, the kinase activities of ZAK are nec-
essary for the negative regulation of RhoGDIβ functions,
including cell cycle arrest, hypertrophic growth, altera-
tions in the amount of membrane-associated Rac1, and
cell migration. Among all the biological functions that are
regulated by RhoGDIβ, the phenomena of hypertrophic
growth and cell migration are Rac1-dependent, whereas
the regulation of the cell cycle arrest is Rac1-independent,
as shown by the results of expression of a dominant-neg-
ative Rac1 (Rac1N17) in RhoGDIβ-expressing cells. It
should be pointed out that the cell migration phenotype
induced in RhoGDIβ-expressing cells seems to result pri-
marily from the rate of migration rather than cell division.
Therefore, RhoGDIβ may stimulate cell migration in a
manner dissociated from its effects on cell cycle progres-
sion.
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Figure S3. SiRNA knockdown of RhoGDIβ inhibited cell migration of 
H9c2 RhoGDIβ-expressing cells.




Figure S4. Confocal microscopy of H9c2 and H9c2 cells expressing the 
indicated proteins.
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